Sold my allocation on open, will look to rebuy if/when it gets to 3.30 or below based on valuation grounds.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025